Cytoskeletal Proteins in Neurological Disorders

Total Page:16

File Type:pdf, Size:1020Kb

Cytoskeletal Proteins in Neurological Disorders cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders. Keywords: actin; tubulin; neurofilaments; microtubules; neuron; growth cone; cytoskeleton; neurological diseases 1. Neuronal Cytoskeleton The cytoskeleton is a cellular organelle formed by a three-dimensional scaffold of proteins that is particularly essential for the definition of the physiological properties of neurons. Since the development of the nervous system and throughout its entire existence, the cytoskeleton is essential to maintain neuronal functions. Neurons are morphologically distinguished from other cells because they have a compartmentalized structure: dendrites, a cell body (or neuronal soma), an axon, and axon terminals. In each compartment, cytoskeletal proteins have specific functions that ensure, as a final goal, the transmission of electrical and chemical signals between neurons. The neuronal cytoskeleton has to be both a flexible and dynamic organelle to maintain the neuronal circuit functioning through the life of an organism. It depends on three classes of filaments: intermediate filaments (IF), which are protein-based neurofilaments (10 nm in diameter), actin-based microfilaments (6 nm in diameter), and tubulin-based microtubules (24 nm in diameter) (Figure1). In addition to these proteins, other filament-binding proteins regulate the organization and dynamics of these components. Cells 2020, 9, 358; doi:10.3390/cells9020358 www.mdpi.com/journal/cells Cells 2020, 9, 358 2 of 41 Cells 2019, 8, x 2 of 43 Figure 1. Main elements of the neuronal cytoskeleton. The neuronal cytoskeleton is mainly Figure 1. Main elements of the neuronal cytoskeleton. The neuronal cytoskeleton is mainly composed composed of neurofilaments, actin filaments, and microtubules. In neurons, actin filaments and of neurofilaments, actin filaments, and microtubules. In neurons, actin filaments and microtubules are microtubules are very dynamic in response to physiological needs, for example, during the very dynamic in response to physiological needs, for example, during the embryonic development of embryonic development of the nervous system and the axonal regeneration of peripheral nerves the nervous system and the axonal regeneration of peripheral nerves after damage. Here, neurons after damage. Here, neurons need to grow a new axon and direct it to their right target. For this need to grow a new axon and direct it to their right target. For this particular task, neurons use the particulargrowth cone,task, aneurons motile structureuse the growth rich in actin cone, and a moti microtubulesle structure as wellrich asin otheractin cytoskeletaland microtubules components. as wellScale as other bar 10 cytoskeletalµm. components. Scale bar 10 μm. In Inneurons, neurons, neurofilaments neurofilaments are are the the structural structural core core of ofmyelinated myelinated axons axons and and modulate modulate the the axonalaxonal diameter diameter [1–3], [1–3 which], which is essential is essential for for mainta maintainingining axonal axonal transport transport [4] [ 4and] and nerve nerve conduction conduction velocityvelocity [5,6]. [5,6 In]. Inmature mature axons, axons, microfilaments microfilaments form form both both stable stable structures, structures, such such as asactin actin rings, rings, and and dynamicdynamic structures, structures, such such as ashotspo hotspotsts and and trails. trails. In Indeveloping developing or orregenerating regenerating axons axons of ofall allneurons, neurons, microfilamentsmicrofilaments form form dynamic dynamic structures, structures, such asas thethe lamellipodia lamellipodia and and filopodia, filopodia, in thein the growth growth cones cones(GCs). (GCs). On theOn otherthe other side, side, microtubules microtubules overlap over tolap provide to provide neurons neurons with with continuous continuous transport transport tracks tracksthat that allow allow active active mitochondrial mitochondrial [7,8], [7,8], vesicular vesicular [9,10 [9,10],], and and mRNA mRNA [11,12 [11,12]] transport transport along along the axonsthe axonsand and in the in growththe growth cone, cone, thus thus ensuring ensuring neuronal neuronal homeostasis. homeostasis. TheseThese three three elements elements (neurofilaments, (neurofilaments, microfil microfilaments,aments, and and microtubules) microtubules) work work together together to to guaranteeguarantee a aproper proper formation formation of thethe nervousnervous system system during during the the embryonic embryonic development development and and to assure to assureits function its function in adulthood. in adulthood. There There are three are three particular particular events events where where the function the function of cytoskeletal of cytoskeletal proteins proteinsis required: is required: first, during first, embryonicduring embryonic development, development, where the where cytoskeleton the cytoskeleton participates participates in the growth in theand growth guidance and ofguidance axons (for of aaxons review (for see, a [review13,14]); second,see, [13,14]); during second, adult life,during where adult neurons life, where depend neuronson the depend cytoskeleton on the for cytoskeleton maintaining for neuronal maintainin homeostasisg neuronal and homeostasis neuronal plasticity and neuronal [15–18 ];plasticity and third, [15–18];when theand peripheral third, when axon the needs peripheral to regenerate axon afterneeds being to regenerate injured. In after this lastbeing event, injured. peripheral In this neurons last event, peripheral neurons (for a review, see [19]) require a specific set of cytoskeletal proteins to ensure nerve regeneration upon damage [20,21]. Given the importance of cytoskeleton for neurons, it is not surprising that several neurological disorders either involve changes in the expression, dynamics, and stability of cytoskeletal proteins Cells 2020, 9, 358 3 of 41 (for a review, see [19]) require a specific set of cytoskeletal proteins to ensure nerve regeneration upon damage [20,21]. Given the importance of cytoskeleton for neurons, it is not surprising that several neurological disorders either involve changes in the expression, dynamics, and stability of cytoskeletal proteins or are the result of their mutations. In this review, we will study the basic knowledge of the structure and function of cytoskeletal proteins in neurons, and highlight discoveries that may be relevant to understand the molecular mechanisms underlying some neurological disorders. 1.1. Intermediate Filaments Intermediate filaments (IFs) are the major cytoskeletal proteins in neurons. In contrast to microfilaments and microtubules, IFs are more heterogeneous, have tensile strength, do not have polarity, and do not participate in cell motility. There are seven classes of IFs-proteins (Table1) and among these, three classes have a distinctive function in cells of the nervous system (neurons and glial cells): Type III (Desmin, DES; the Glial Fibrillary Acidic Protein, GFAP; Peripherin, PRPH and Vimentin, VIM); Type IV (α-Internexin, INA; Neurofilament light, NF-L; Neurofilament medium, NF-M; Neurofilament heavy, NF-H and Syncoilin, SYNC); and Type VI (Nestin, NES and Synemin, SYNM). Table 1. Classification of intermediate filaments. Intermediate Filament Protein Name Gene Name Uniprot ID Type I and II Acidic and basic keratins 44 genes Desmin DES P17661 Type III Glial fibrillary acidic protein GFAP P14136 Peripherin PRPH P41219 Vimentin VIM P08670 Internexin neuronal intermediate filament INA Q16352 protein, alpha Neurofilament light polypeptide NEFL P07196 Type IV Neurofilament medium polypeptide NEFM P07197 (neurofilament 3) Neurofilament heavy polypeptide NEFH P12036 Syncoilin 1 SYNC Q9H7C4 Lamin A/C LMNA P02545 Type V LMNB1 P20700 Lamin B LMNB2 Q03252 Nestin NES P48681 Type VI Synemin SYNM O15061
Recommended publications
  • ENSG Gene Encodes Effector TCR Pathway Costimulation Inhibitory/Exhaustion Synapse/Adhesion Chemokines/Receptors
    ENSG Gene Encodes Effector TCR pathway Costimulation Inhibitory/exhaustion Synapse/adhesion Chemokines/receptors ENSG00000111537 IFNG IFNg x ENSG00000109471 IL2 IL-2 x ENSG00000232810 TNF TNFa x ENSG00000271503 CCL5 CCL5 x x ENSG00000139187 KLRG1 Klrg1 x ENSG00000117560 FASLG Fas ligand x ENSG00000121858 TNFSF10 TRAIL x ENSG00000134545 KLRC1 Klrc1 / NKG2A x ENSG00000213809 KLRK1 Klrk1 / NKG2D x ENSG00000188389 PDCD1 PD-1 x x ENSG00000117281 CD160 CD160 x x ENSG00000134460 IL2RA IL-2 receptor x subunit alpha ENSG00000110324 IL10RA IL-10 receptor x subunit alpha ENSG00000115604 IL18R1 IL-18 receptor 1 x ENSG00000115607 IL18RAP IL-18 receptor x accessory protein ENSG00000081985 IL12RB2 IL-12 receptor x beta 2 ENSG00000186810 CXCR3 CXCR3 x x ENSG00000005844 ITGAL CD11a x ENSG00000160255 ITGB2 CD18; Integrin x x beta-2 ENSG00000156886 ITGAD CD11d x ENSG00000140678 ITGAX; CD11c x x Integrin alpha-X ENSG00000115232 ITGA4 CD49d; Integrin x x alpha-4 ENSG00000169896 ITGAM CD11b; Integrin x x alpha-M ENSG00000138378 STAT4 Stat4 x ENSG00000115415 STAT1 Stat1 x ENSG00000170581 STAT2 Stat2 x ENSG00000126561 STAT5a Stat5a x ENSG00000162434 JAK1 Jak1 x ENSG00000100453 GZMB Granzyme B x ENSG00000145649 GZMA Granzyme A x ENSG00000180644 PRF1 Perforin 1 x ENSG00000115523 GNLY Granulysin x ENSG00000100450 GZMH Granzyme H x ENSG00000113088 GZMK Granzyme K x ENSG00000057657 PRDM1 Blimp-1 x ENSG00000073861 TBX21 T-bet x ENSG00000115738 ID2 ID2 x ENSG00000176083 ZNF683 Hobit x ENSG00000137265 IRF4 Interferon x regulatory factor 4 ENSG00000140968 IRF8 Interferon
    [Show full text]
  • Isyte: Integrated Systems Tool for Eye Gene Discovery
    Lens iSyTE: Integrated Systems Tool for Eye Gene Discovery Salil A. Lachke,1,2,3,4 Joshua W. K. Ho,1,4,5 Gregory V. Kryukov,1,4,6 Daniel J. O’Connell,1 Anton Aboukhalil,1,7 Martha L. Bulyk,1,8,9 Peter J. Park,1,5,10 and Richard L. Maas1 PURPOSE. To facilitate the identification of genes associated ther investigation. Extension of this approach to other ocular with cataract and other ocular defects, the authors developed tissue components will facilitate eye disease gene discovery. and validated a computational tool termed iSyTE (integrated (Invest Ophthalmol Vis Sci. 2012;53:1617–1627) DOI: Systems Tool for Eye gene discovery; http://bioinformatics. 10.1167/iovs.11-8839 udel.edu/Research/iSyTE). iSyTE uses a mouse embryonic lens gene expression data set as a bioinformatics filter to select candidate genes from human or mouse genomic regions impli- ven with the advent of high-throughput sequencing, the cated in disease and to prioritize them for further mutational Ediscovery of genes associated with congenital birth defects and functional analyses. such as eye defects remains a challenge. We sought to develop METHODS. Microarray gene expression profiles were obtained a straightforward experimental approach that could facilitate for microdissected embryonic mouse lens at three key devel- the identification of candidate genes for developmental disor- opmental time points in the transition from the embryonic day ders, and, as proof-of-principle, we chose defects involving the (E)10.5 stage of lens placode invagination to E12.5 lens primary ocular lens. Opacification of the lens results in cataract, a leading cause of blindness that affects 77 million persons and fiber cell differentiation.
    [Show full text]
  • A New Mutation in BFSP2 (G1091A) Causes Autosomal Dominant Congenital Lamellar Cataracts
    Molecular Vision 2008; 14:1906-1911 <http://www.molvis.org/molvis/v14/a226> © 2008 Molecular Vision Received 17 August 2008 | Accepted 18 October 2008 | Published 24 October 2008 A new mutation in BFSP2 (G1091A) causes autosomal dominant congenital lamellar cataracts Xu Ma,1,2,3 Fei-Feng Li,1,2 Shu-Zhen Wang,4 Chang Gao,1,2 Meng Zhang,2 Si-Quan Zhu4 (The first three authors contributed equally to this work.) 1Graduate School, Peking Union Medical College, Beijing, China; 2Department of Genetics, National Research Institute for Family Planning, Beijing, China; 3WHO Collaborative Center for Research in Human Reproduction, Beijing, China; 4Beijing Tongren Eye Center, Capital Medical University, Beijing, China Purpose: We sought to identify the genetic defect in a four-generation Chinese family with autosomal dominant congenital lamellar cataracts and demonstrate the functional analysis with biosoftware of a candidate gene in the family. Methods: Family history data were recorded. Clinical and ophthalmologic examinations were performed on family members. All the members were genotyped with microsatellite markers at loci considered to be associated with cataracts. Two-point LOD scores were calculated by using the Linkage Software after genotyping. A mutation was detected by using gene-specific primers in direct sequencing. Wild type and mutant proteins were analyzed with Online Bio-Software. Results: Affected members of this family had lamellar cataracts. Linkage analysis was obtained at markers D3S2322 (LOD score [Z]=7.22, recombination fraction [θ]=0.0) and D3S1541 (Z=5.42, θ=0.0). Haplotype analysis indicated that the cataract gene was closely linked to these two markers.
    [Show full text]
  • Unsheathing WASP's Sting
    news and views required for Swallow-mediated localiza- Cytoplasmic dynein is implicated in Minneapolis 55455, Minnesota, USA tion within the oocyte. many biological processes, including ves- e-mail:[email protected] The interaction between Swallow and icle and organelle transport, mitotic- Roger Karess is at the CNRS Centre de Génétique Dlc is a significant finding and provides spindle function and orientation, and Moléculaire, Ave de la Terrasse, 91198 Gif-sur- the basis for a model in which the dynein- now RNA transport and localization. It is Yvette, France motor complex is responsible for the important to emphasize that a single iso- e-mail: [email protected] anterior localization of bicoid RNA within form of the dynein-motor subunit is 1. St Johnston, D. Cell 81, 167–170 (1995). the oocyte. Interestingly, the transient known to be targeted to several cellular 2. Bashirullah, A., Cooperstock, R. & Lipshitz, H. Annu. Rev. localization of Swallow to the oocyte functions and molecular cargoes within Biochem. 67, 335–394 (1998). anterior occurs at a time when most of the individual cells. Thus it is those molecules 3. Oleynikov, Y. & Singer, R. Trends Cell Biol. 8, 381–383 dynein-motor subunits are concentrated with adaptor functions, such as those pro- (1998). 13 4. Wilhelm, J. & Vale, R. J. Cell Biol. 123, 269–274 (1993). at the posterior of the oocyte . This raises posed here for Swallow, that must 5. Schnorrer, F., Bohmann, K. & Nusslein-Volhard, C. Nature Cell the possibility that at least two distinct account for the functional specificity of Biol.
    [Show full text]
  • Actin Cytoskeleton of Spread Fibroblasts Appears to Assemble at the Cell Edges
    J. Cell Sd. 82, 235-248 (1986) 235 Printed in Great Britain © The Company of Biologists Limited 1986 ACTIN CYTOSKELETON OF SPREAD FIBROBLASTS APPEARS TO ASSEMBLE AT THE CELL EDGES TATJANA M. SVITKINA, ALEXANDER A. NEYFAKH, JR Laboratory of Molecular Biology and Bioorganic Chemistry, Moscow State University, Moscow 119899, USSR AND ALEXANDER D. BERSHADSKY All-Union Cancer Research Center, Academy of Medical Sciences, Moscow 115478, USSR SUMMARY The action of metabolic inhibitors on actin cytoskeleton of cultured quail embryo fibroblasts has been studied using electron microscopy of platinum replicas and immunofluorescence microscopy. Sodium azide as well as other inhibitors (oligomycin and dinitrophenol) caused the disassembly of all types of actin structures: actin meshwork at the cell active edges, microfilament sheath underlying the cell surface, and microfilament bundles. Studying the time- and dose-dependence of the destruction process we have found that the active edge meshwork and microfilament sheath are much more labile than microfilament bundles. After the removal of metabolic inhibitors actin cytoskeleton restoration begins at the cell edges. The first sign of this process is the formation of actin meshwork along the whole cell perimeter (l-10min of recovery). Sometimes fragments of this meshwork bend upwards forming ruffles. Later (10-20 min of recovery) the microfilament sheath appears at the cell periphery as a narrow band. The sheath seems to be formed from the edge meshwork, since ruffles in the process of transformation to sheath could be seen. During the following restoration the microfilament sheath gradually expands towards the cell centre. The last step of actin cytoskeleton restoration (60—120 min of recovery) is the formation of bundles.
    [Show full text]
  • The CAP-Gly and Basic Microtubule Binding Domains of Dynactin Are
    Knockdown of dynactin’s p150Glued subunit abrogates microtubule organization by Jared Todd Roeckner A Thesis Submitted to the Faculty of The Wilkes Honors College In Partial Fulfillment of the Requirements for the Degree of Bachelor of Arts in Liberal Arts and Sciences with a Concentration in Biology Wilkes Honors College of Florida Atlantic University Jupiter, Florida May 2009 Knockdown of dynactin’s p150Glued subunit abrogates microtubule organization by Jared T. Roeckner This thesis was prepared under the direction of the candidate’s thesis advisor, Dr. Nicholas Quintyne, and has been approved by the members of the supervisory committee. It was submitted to the faculty of The Honors College and was accepted in partial fulfillment of the Requirements for the Degree of Bachelor of Arts in Liberal Arts and Sciences. SUPERVISORY COMMITTEE: ________________________ Dr. Nicholas Quintyne ________________________ Dr. Paul Kirchman ________________________ Dean, Wilkes Honors College _________ Date ii ACKNOWLEDGEMENTS First, I would like to thank Dr. Nicholas Quintyne for allowing me to work in his lab for the last three years and overseeing and guiding my thesis research and writing. I would like to acknowledge Dr. Stephen King and Dr. Margret Kincaid at UMKC for providing us with the p150Glued knockdown plasmids. Dr. Paul Kirchman, April Mistrik, and everyone in the Quintyne lab helped me out greatly. Ed Fulton and I worked on many steps of this project together and I thank him for his help. Finally, I would like to thank my family and friends for supporting of my thesis research and my undergraduate studies as a whole. iii ABSTRACT Author: Jared Todd Roeckner Title: Knockdown of dynactin’s p150Glued subunit abrogates microtubule organization Institutions: Harriet L.
    [Show full text]
  • HTS-Tubulin Polymerization Assay Biochem Kit™
    The Protein Manual Experts Cytoskeleton, Inc. V 8.0 HTS-Tubulin Polymerization Assay Biochem Kit™ (>97% pure tubulin, Porcine Tubulin) Cat. # BK004P Phone: (303) 322.2254 Fax: (303) 322.2257 Customer Service: [email protected] cytoskeleton.com Technical Support: [email protected] cytoskeleton.com Page 2 Manual Contents Section I: Introduction About Tubulin -------------------------------------------------------------------------- 5 About the BK004P polymerization Assay -------------------------------------- 6-7 Comparison of Polymerization Assays ----------------------------------------- 8-9 Section II: Purchaser Notification ------------------------------------------------------------ 10 Section III: Kit Contents ------------------------------------------------------------------------- 11-12 Section V: Reconstitution and Storage of Components ----------------------------- 13 Section IV: Important Technical Notes Notes on Updated version --------------------------------------------------------- 14 Spectrophotometer settings ------------------------------------------------------- 14 Spectrophotometer pathlength---------------------------------------------------- 15 Temperature & time dependence of polymerization ------------------------ 15 Recommended pipetting technique --------------------------------------------- 15-16 Tubulin protein stability ------------------------------------------------------------- 16 Test compound or protein preparation ------------------------------------------ 16-17 Section VI: Assay Protocol
    [Show full text]
  • Table 1 Gene Name Increased Or Decreased in LTD
    Table_1 gene_name increased or decreased in LTD protein_id description keep_supernatant keep_pellet comparison sample hit_annotation_methodpvalue fdr hit hit_annotation 2010300C02RIK increased E9Q3M9 Protein 2010300C02Rik OS=Mus musculus GN=2010300C02Rik PE=1 SV=1 TRUE TRUE NMDA - control pellet fdrtool 0,074667 0,584087 FALSE trend 2310035C23RIK|KIAA1468increased A0A087WSS1|E9QM90|Q148V7|Q148V7-2 Protein 2310035C23Rik OS=Mus musculus GN=2310035C23Rik PE=1 SV=1|Protein 2310035C23Rik OS=Mus musculusTRUE GN=2310035C23Rik PE=1 SV=2|LisH FALSE domain NMDAand HEAT - control repeat-containing protein KIAA1468 supernatant OS=Mus musculus GN=Kiaa1468 fdrtoolPE=1 SV=1|Isoform 0,080056 2 of 0,589077LisH domain FALSEand HEAT trend repeat-containing protein KIAA1468 OS=Mus musculus GN=Kiaa1468 ABR increased E9PUE7|Q5SSL4|Q5SSL4-2|Q5SSL4-3|Q5SSL4-4 Active breakpoint cluster region-related protein OS=Mus musculus GN=Abr PE=1 SV=1|Isoform 2 of Active breakpointTRUE cluster region-related protein TRUE OS=Mus musculus NMDA GN=Abr|Isoform - control 3 of Active breakpoint supernatant cluster region-related protein OS=Mus fdrtool musculus 0,08128 GN=Abr|Isoform 0,592743 4 of Active FALSE breakpoint trend cluster region-related protein OS=Mus musculus GN=Abr ADAM22 increased D3YUP9|Q9R1V6|Q9R1V6-10|Q9R1V6-11|Q9R1V6-12|Q9R1V6-13|Q9R1V6-14|Q9R1V6-15|Q9R1V6-17|Q9R1V6-4|Q9R1V6-5|Q9R1V6-6|Q9R1V6-7|Q9R1V6-8Disintegrin and metalloproteinase domain-containing protein 22 OS=Mus musculus GN=Adam22 PE=1 SV=1|DisintegrinFALSE and metalloproteinase domain-containing TRUE
    [Show full text]
  • Regulation of Cardiovascular Homeostasis by Autophagy
    Georgia State University ScholarWorks @ Georgia State University Chemistry Dissertations Department of Chemistry 12-16-2020 Regulation Of Cardiovascular Homeostasis By Autophagy Jing Mu Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_diss Recommended Citation Mu, Jing, "Regulation Of Cardiovascular Homeostasis By Autophagy." Dissertation, Georgia State University, 2020. https://scholarworks.gsu.edu/chemistry_diss/190 This Dissertation is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Chemistry Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. REGULATION OF CARDIOVASCULAR HOMEOSTASIS BY AUTOPHAGY by JING MU Under the Direction of Ming-hui Zou, MD/PhD ABSTRACT Macroautophagy (hereafter autophagy) is a fundamental cellular process that removes unnecessary or dysfunctional components. It allows the orderly degradation and recycling of cellular components. Mitophagy refers to the selective removal of damaged mitochondria via autophagy pathway. In addition to utilizing core autophagic machinery components, mitophagy exploits a variety of molecules, such as PTEN-induced putative kinase protein 1 (PINK1) and Parkin, to identify and eliminate damaged or superfluous mitochondria. Dysregulation of autophagy and mitophagy contributes to a variety of human disorders, including cardiovascular diseases, such as atherosclerosis and diabetic cardiomyopathy. Vascular smooth muscle cells (VSMCs) are a major component of the vascular media, and are vital for maintaining vessel homeostasis. Migration of VSMCs from the media to intima occurs during the development of atherosclerosis. Although alterations in autophagy activity have been reported in atherosclerosis, further investigation is required to delineate the mechanism by which autophagy regulates microtubule stability and cell migration.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Netwo
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2014 An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis Sriram Devanathan Washington University School of Medicine in St. Louis Timothy Whitehead Washington University School of Medicine in St. Louis George G. Schweitzer Washington University School of Medicine in St. Louis Nicole Fettig Washington University School of Medicine in St. Louis Attila Kovacs Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Devanathan, Sriram; Whitehead, Timothy; Schweitzer, George G.; Fettig, Nicole; Kovacs, Attila; Korach, Kenneth S.; Finck, Brian N.; and Shoghi, Kooresh I., ,"An animal model with a cardiomyocyte-specific deletion of estrogen receptor alpha: Functional, metabolic, and differential network analysis." PLoS One.9,7. e101900. (2014). https://digitalcommons.wustl.edu/open_access_pubs/3326 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Sriram Devanathan, Timothy Whitehead, George G. Schweitzer, Nicole Fettig, Attila Kovacs, Kenneth S. Korach, Brian N. Finck, and Kooresh I. Shoghi This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/3326 An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis Sriram Devanathan1, Timothy Whitehead1, George G. Schweitzer2, Nicole Fettig1, Attila Kovacs3, Kenneth S.
    [Show full text]
  • The Spectraplakin Dystonin Antagonizes YAP Activity and Suppresses Tumourigenesis Praachi B
    www.nature.com/scientificreports OPEN The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis Praachi B. Jain1,2,3, Patrícia S. Guerreiro1,2,3, Sara Canato1,2,3 & Florence Janody 1,2,3* Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underlying molecular mechanism. We show that in MCF10A cells, Dystonin is necessary to restrain cell growth, anchorage-independent growth, self-renewal properties and resistance to doxorubicin. Strikingly, while Dystonin maintains focal adhesion integrity, promotes cell spreading and cell-substratum adhesion, it prevents Zyxin accumulation, stabilizes LATS and restricts YAP activation. Moreover, treating DST- depleted MCF10A cells with the YAP inhibitor Verteporfn prevents their growth. In vivo, the Drosophila Dystonin Short stop also restricts tissue growth by limiting Yorkie activity. As the two Dystonin isoforms BPAG1eA and BPAG1e are necessary to inhibit the acquisition of transformed features and are both downregulated in breast tumour samples and in MCF10A cells with conditional induction of the Src proto-oncogene, they could function as the predominant Dystonin tumour suppressor variants in breast epithelial cells. Thus, their loss could deem as promising prognostic biomarkers for breast cancer. Breast cancer progression depends on cell autonomous regulatory mechanisms, driven by mutations and epi- genetic changes, and on non-cell autonomous interactions with the surrounding tumour microenvironment1,2. During this multistep process, normal breast epithelial cells acquire various cellular properties arising from dereg- ulated cellular signalling3,4.
    [Show full text]